Jump to search

July 2016arrow

UC Davis scientists awarded grant for rare genetic disorder research

July 21, 2016

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved a $1.1 million grant to UC Davis for research aimed at developing a treatment for Angelman syndrome,  a rare, neurogenetic autism-spectrum disorder that occurs in one in 15,000 live births.

May 2016arrow

De Vere White to step down as long-time UC Davis Comprehensive Cancer Center director

May 31, 2016

Ralph de Vere White, a beloved urologist and acclaimed researcher who led the UC Davis Comprehensive Cancer to designation by the National Cancer Institute (NCI), steps down as its long-time director on June 29.

National Cancer Institute re-designates the cancer center

May 17, 2016

The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves.

April 2016arrow

Stem cell research reveals myelin repair capacity

April 28, 2016

In a study published today in Cell Reports, Wenbin Deng and his colleagues present data showing that immature astroglial transplants, derived from human-induced pluripotent stem cells (iPSCs), are highly protective against white matter brain injury — which can occur from lack of oxygen following a stroke or in childbirth — and can improve spatial learning and memory function in mouse models.

New study tests stem cells as a treatment for degenerative disc disease

April 25, 2016

As part of a new multicenter clinical trial, UC Davis Health System researchers will test whether a novel stem cell treatment can reduce the pain and mobility issues caused by degenerative disc disease.

March 2016arrow

State stem cell agency approves research funding for UC Davis scientists

March 21, 2016

Two new UC Davis research efforts, one aimed at addressing fatal early childhood conditions known as Tay-Sachs and Sandhoff disease, the other designed to develop an immunotherapy that would eradicate solid tumor cancer stem cells and create sustained anti-tumor effects, have been approved for funding by the California Institute for Regenerative Medicine (CIRM).

Human stem cells target Huntington's disease

March 15, 2016

In a promising finding for research into Huntington’s disease (HD) — the devastating inherited neurodegenerative disorder — a team of UC Davis investigators has identified for the first time a way to use human mesenchymal stem cells (MSCs) to deliver the key brain protein growth factor that is dramatically diminished by Huntington’s disease.

February 2016arrow

New study tests stem cells as a treatment for degenerative disc disease

February 10, 2016

As part of a new multicenter clinical trial, UC Davis Health System researchers will test whether a novel stem cell treatment can reduce the pain and mobility issues caused by degenerative disc disease.

January 2016arrow

Researchers decipher stem cell messages in blood vessel formation

January 19, 2016

An international collaboration between UC Davis and Swedish scientists has resulted in the first comprehensive characterization of a recently discovered cell-to-cell communication system used by stem cells.

December 2015arrow

Two UC Davis experts among speakers at World Stem Cell Summit

December 9, 2015

Two UC Davis Health System scientists are among the featured speakers at the upcoming World Stem Cell Summit and Regenerative Medicine conference that starts Dec. 10 in Atlanta.